Company Announcements - 2011
-
Company Secretary Resignation and Appointment23 December 2011
Analytica Limited (Analytica) advises that Jennie Yuen has resigned as Company Secretary and Tom Rowe has been appointed as company secretary, effective immediately.
As Ms Yuen and Mr Rowe both work as solicitors for Company Matters Pty Limited, this is a continuation of the existing engagement between Analytica and Company Matters Pty Limited and ensures a seamless transition.
Analytica's Board thanks Ms Yuen for her valuable assistance and advice during her time as Company Secretary and wishes her well with her future endeavours.
-
Appendix 3Y (x3)23 December 2011
Change of Director's Interest Notice
-
Section 708A(5)(e) ('Cleansing') Notice22 December 2011
-
Appendix 3B22 December 2011
New issue announcement, application for quotation of additional securities and agreement.
-
Non-Renounceable Rights Issue Raises $2.8 Million14 December 2011
Analytica advises the Rights Issue closed on 9 December 2011 raised approximately $2.8M. The Rights Issue was fully subscribed when combined with the underwritten amount.
-
Section 708A(5)(e) ('Cleansing') Notice6 December 2011
-
Appendix 3B6 December 2011
New issue announcement, application for quotation of additional securities and agreement.
-
Appendix 3B1 December 2011
New issue announcement, application for quotation of additional securities and agreement.
-
Wise-Owl.com Research Report30 November 2011
Analytica Limited (ASX:ALT) is pleased to advise the release of an independent research report from Wise-Owl.com dated 30 November 2011.
-
Annual General Meeting29 November 2011
-
Rights Issue - Extension of Offer Period28 November 2011
Analytica Limited advises that the offer period for the current rights issue has been extended to now close on 9 December 2011.
-
Eligible Shareholder Rights Issue Entitlement and Acceptance Form16 November 2011
-
Rights Issue Letters to Shareholders3 November 2011
-
Rights Issue Prospectus2 November 2011
A non-renounceable rights issue of 1 New Share for every 3 Shares held at 2 cents each together with 1 New 4 Cent Option and 1 New 8 Cent Option for every 1 New Share.
-
Appendix 3B (Rights Issue)2 November 2011
New issue announcement, application for quotation of additional securities and agreement.
-
Appendix 3B2 November 2011
New issue announcement, application for quotation of additional securities and agreement.
-
Option to Acquire Patent for Pelvic Floor Exercise System (CORRECTION)1 November 2011
Analytica wishes to correct the announcement released earlier today regarding the patent for the pelvic floor exercise system. The reference to the exclusive option to receive the assignment of the Australian Patent for the pelvic floor exercise system is incorrect, and should instead be a reference to the assignment of intellectual property relating to the pelvic floor exercise system.
-
Option to Acquire Patent for Pelvic Floor Exercise System1 November 2011
Analytica has been granted an exclusive option to receive the assignment of the Australian patent for the pelvic floor exercise system. The option will expire on 25 October 2014.
-
Appendix 4C - Quarterly Cash Flow31 October 2011
Analytica Ltd presents its Appendix 4C for the quarter ended 30 September 2011.
-
Notice of Annual General Meeting27 October 2011
Notice is given that the Annual General Meeting of shareholders of Analytica Limited will be held on Tuesday 29 November 2011 at 9:00am (Brisbane time) in the East Auditorium at Brisbane Technology Park Conference Centre, 1 Clunies Ross Court (off Miles Platting Road), Eight Mile Plains, Queensland.
-
Analytica Limited Annual Report for the Year Ended 30 June 201127 October 2011
-
Consolidated Financial Statements28 September 2011
Your Directors present their report, together with the statement of the consolidated group, being the Company and its controlled entities, for the financial year ended 30 June 2011.
-
Appendix 4E25 August 2011
Preliminary Final Report
-
Appendix 4C29 July 2011
Analytica Ltd presents its Appendix 4C for the quarter ended June 2011.
-
Appendix 3Z25 July 2011
Final Director's Interest Notice - David Gooch.
-
Appendix 3X25 July 2011
Initial Director's Interest Notice - Warren Brooks.
-
Director Appointment and Resignation25 July 2011
Analytica Limited is pleased to announce the appointment of Mr Warren Stephen Brooks as a non-executive director of the Company. The Board also wishes to announce the resignation of Mr. David Gooch.
-
Supply Agreement Secured for AutoStart Burette with Concord Repatriation and General Hospital6 July 2011
Analytica Limited and Medical Australia Limited are pleased to announce that a major clinical trial using Analytica's AutoStart Burette has been successfully completed in Sydney, Australia with Concord Repatriation and General Hospital.
-
Supply Agreement Secured for AutoStart Burette with New South Wales Ambulance Service12 May 2011
Analytica Limited and Medical Australia Limited are pleased to announce that the first order has been completed under the distribution agreement signed in April 2010. NSW Ambulance Service has placed an ongoing order for AutoStart® Burettes and these devices will be carried by ambulances across the state.
-
Appendix 4C - Quarterly Cash Flow20 April 2011
Analytica Ltd presents its Appendix 4C for the quarter ended 31 March 2011.
-
Appendix 4D - Half Yearly Report28 February 2011
Your directors submit their report for the half-year ended 31 December 2010.
-
ASX Price Query25 February 2011
Regarding the increase in the price of Analytica's securities from 2.4 cents at the close of trade on Wednesday 23 February 2011 to an intra-day high of 3.8 cents on 25 February 2011 and the increase in the volume of securities traded over this period.
-
Appendix 4C - Quarterly Cash Flow31 January 2011
Analytica Ltd presents its Appendix 4C for the quarter ended 31 December 2010.